Furthermore, evidence suggests that IR, along with the associated hyperglycemia, occurs in classic insulin target organs, and that these conditions are the pathological hallmark of metabolic disorders such as obesity and T2D [46]. This evidence concerns the gene INS and type 2 diabetes mellitus.